Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Hepa/Biliary Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Hepa/Biliary Other
    Adding Cetuximab to Chemotherapy Increases Tumour Shrinkage In Advanced Colorectal Cancer - (DGNews)
    New Drug Regimen Shows Promising Results for Advanced Biliary-Tract Cancers - (DGNews)
    Statin use and risk of gallstone disease followed by cholecystectomy - (JAMA)
    What Is the Optimal Timing of Hepatitis C Antiviral Therapy Before and After Liver Transplantation? Presented at AASLD - (DGDispatch)
    Alcohol Does Not Appear to Increase Acetaminophen-Related Acute Liver Failure: Presented at AASLD - (DGDispatch)

    News archive

     Recent webcasts/CME - Hepa/Biliary Other
    • Active Ulcerative Colitis: Selection of First-Line Therapies for Better Patient Outcomes
    • Alpha1-Antitrypsin Augmentation: Approaches and Benefits
      Drug-Induced Liver Disease, Part 2
      Drug-Induced Liver Disease, Part 1
      The Meso-Rex Bypass for Portal Hypertension in Children

      Webcasts/CME archive

       Recent cases - Hepa/Biliary Other
        Liver Abscess And Sepsis With Bacillus Pantothenticus In An Immunocompetent Patient: A First Case Report
        Abscess of the Round Ligament of the Liver Associated with Acute Obstructive Cholangitis and Septic Thrombosis
        An Atypical Case of Hepatic Cavernous Hemangioma: A Case Report
        Cholecystopleural Fistula in a 71-Year-Old Man with Symptoms of Pneumonia and Pleural Effusion
        Hypercalcemia in a Patient with Cholangiocarcinoma: A Case Report

        Cases archive
          




        my personal edition > hepa/biliary other > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Liver Tests Fail to Measure Up to CPS II in Biliary Cirrhosis

        A DGReview of :"Quantitative testing of liver function compared to prognostic scores in patients with primary biliary cirrhosis"
        Liver

        06/14/2002
        By Mark Pownall


        The best method of measuring the progress of primary biliary cirrhosis is the established Christiansen prognosis score (CPS), a comparison of different measures has concluded.

        But, the comparison also indicates that the second version of the prognosis score, CPS II, is a better measure of disease progression.

        A proposed alternative method of assessing prognosis using quantitative tests of liver function, did not appear to be as sensitive to change as CPS II.

        Researchers from the University of Erlangen-Nuernberg in Germany followed 34 patients with primary biliary cirrhosis over two years. At the beginning of the study, the patients were investigated with CPS I and II, and the Mayo prognosis score. They also had serum levels of a surrogate marker for hepatic fibrogenesis (PIINP) measured, as well as other parameters relevant to primary biliary cirrhosis, and quantitative tests of liver function. The patients also underwent histological staging of their condition.

        The liver tests carried out included the aminopyrine breath test, galactose elimination capacity, and sorbitol and indocyanine green clearance. The tests were repeated after two years. Bilirubin, serum IgM and PIINP were raised at both times of measurement, but albumin and prothrombin levels remained normal.

        Clinical findings of ascites, cirrhosis and central cholestasis were worse after two years, as was histological staging. Despite this progression of disease, the liver tests CPS I and Mayo scores barely changed.

        The researchers concluded that the quantitative liver tests and the measurement of the fibrogenesis marker added nothing to assessment of progression of the biliary cirrhosis over two years, and that CPS II is better for measurement of prognosis in the short term.
        Liver 2002; 22(2): 159-165. "Quantitative testing of liver function compared to prognostic scores in patients with primary biliary cirrhosis"

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send